CROI 2016 Program at a Glance

Program and Agenda

Session O-10 Oral Abstracts 10:00 AM-12:00 PM Getting to 90-90-90 Oral Abstract Moderators

Ballroom A

11:15 116 Virologic Efficacy of ART Begun at High CD4+ Counts via Streamlined Care in East Africa Dalsone Kwarisiima 1 ;Vivek Jain 2 ; Asiphas Owaraganise 3 ; Florence Mwangwa 3 ; Dathan Byonanebye 4 ; James Ayieko 5 ; Maya Petersen 6 ; DianeV. Havlir 2 ; Moses R. Kamya; for the SEARCH Collaboration

Lisa J. Nelson ,U.S.DepartmentofState,Washington ,DC,USA Marco Vitoria ,WorldHealthOrganization,Geneva,Switzerland 10:00 111 Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage

1 MakerereUniv-UnivofCaliforniaSanFranciscoRsrCollab, Kampala,Uganda; 2 UnivofCaliforniaSanFrancisco,San Francisco,CA,USA; 3 InfectiousDiseasesRsrCollab,Kampala, Uganda; 4 MakerereUnivCollofHlthScis,Kampala,Uganda; 5 KenyaMedRsr Inst,Kisumu,Kenya; 6 UnivofCaliforniaBerkeley, Berkeley,CA,USA

Tendani Gaolathe 1 ; KathleenWirth 2 ; Molly Pretorius Holme 2 ; Joseph Makhema 1 ; Sikhulile Moyo 3 ; EricTchetgenTchetgen 2 ; Refeletswe Lebelonyane 4 ; Lisa A. Mills 5 ; M. Essex 2 ; Shahin Lockman 6 1 BotswanaHarvardAIDS InstPartnership,Gaborone,Botswana;

11:30 117 HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility

2 HarvardSchofPH,Boston,MA,USA; 3 BotswanaHarvard AIDS InstPartnership,Gaborone,Botswana; 4 MinistryofHlth, Gaborone,Botswana; 5 CDC,Gaborone,Botswana; 6 Brighamand Women’sHosp,HarvardMedSch,Boston,MA,USA 10:15 112 Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial Gideon Amanyire 1 ; Fred Collins Semitala 1 ; Jennifer Namusobya 1 ; Richard Katuramu 2 ; Leatitia Kampiire 2 ; JeannaWallenta 3 ; David V. Glidden 3 ; Moses R. Kamya; DianeV. Havlir 3 ; Elvin H. Geng 3 1 MakerereUnivCollofHlthScis,Kampala,Uganda; 2 Infectious DiseasesRsrCollab,Kampala,Uganda; 3 UnivofCaliforniaSan Francisco,SanFrancisco,CA,USA 10:30 113LB A Randomized Trial to Accelerate HIV Care and ART Initiation Following HIV Diagnosis 1 JohnsHopkinsUnivSchofMed,Baltimore,MD,USA; 2 Aurum Inst, Johannesburg,SouthAfrica; 3 LondonSchofHygiene&TropMed, London,UK; 4 JohnsHopkinsUnivBloombergSchoolofPublic Hlth,Baltimore,MD,USA; TheAurum Inst, Johannesburg,South Africa 10:45 114 Towards the Second UNAIDS Target: Population- Level ART Coverage in HPTN 071 (PopART) Christopher Hoffmann 1 ;Tonderai Mabuto 2 ; Sibuse Ginindza 2 ; Katherine L. Fielding 3 ; Griffiths Kubeka 2 ; David Dowdy 4 ; Gavin Churchyard 5 ; Salome Charalambous 5

Eran Bendavid 1 ; Anna Bershteyn 2 ; Andrew Boulle 3 ; Jeffrey W. Eaton 4 ;Timothy Hallett 4 ; Daniel J. Klein 2 ; Jack J. Olney 4 ; Andrew N. Phillips 5 ; Emma Slaymaker 6 ; for the HIV Modelling

ConsortiumWriting Group on ART Eligibility Guidelines 1 StanfordUniv,Stanford,CA,USA; 2 Inst forDiseaseModeling, Bellevue,WA,USA; 3 Cntr for InfectiousDiseaseEpiandRsr,Cape Town,SouthAfrica; 4 ImperialCollLondon,London,UK; 5 UnivColl London,London,UK; 6 LondonSchofHygiene&TropMed,London, UK 11:45 118 Trends in ART Discontinuation by Age in Malawi, 2004–2014

Wednesday, February 24, 2016 • Oral Sessions

Catrina A. Mugglin 1 ; Andreas Haas 1 ; Joep van Oosterhout 2 ; Frank Chimbwandira 3 ; LysonTenthani 1 ; Malango Msukwa 4 ; Oliver Gadabu 5 ; Janne Estill 1 ; Matthias Egger 6 ; Olivia Keiser 1 1 InstofSocialandPreventiveMed,UnivofBern,Bern, Switzerland; 2 Dignitas Intl,Zomba,Malawi; 3 MalawiMinistryof Hlth,Lilongwe,Malawi; 4 InstofSocialandPreventiveMed,Univ ofBern,Lilongwe,Malawi; 5 BaobabHlthTrust,Lilongwe,Malawi; 6 UnivHospBern,Bern,Switzerland

Session TD-7 Themed Discussion

Room 304/306

1:45 PM-2:45 PM Stroke: Incidence and Risk Factors Themed Discussion Leader Richard W. Price ,UniversityofCaliforniaSanFrancisco,SanFrancisco,CA,US 636 Design, Implementation, and Findings of Next- Generation Stroke Adjudication in HIV Heidi M. Crane 1 ; Felicia Chow 2 ; Kyra J. Becker 1 ; Christina Marra 1 ; Joseph Zunt 1 ; Emily L. Ho 1 ; RIzwan Kilani 1 ; Robin Nance 1 ; Joseph A. Delaney 3 ; DavidTirchwell 1 1 UnivofWashington,Seattle,WA,USA; 2 UnivofCaliforniaSanFrancisco, SanFrancisco,CA,USA; 3 UnivofWashingtonSchofPHandCommunity Med,Seattle,WA,USA

Sarah J. Fidler 1 ; Sian Floyd 2 ; BliaYang 3 ; Kwame Shanaube 4 ; Peter Bock 3 ; Ab Schaap 4 ; Kaplana Sabapathy 2 ; Helen Ayles 2 ; Richard Hayes 2 ; for the HPTN 071 (PopART) study team

1 ImperialCollLondon,London,UK; 2 LondonSchofHygiene&Trop Med,London,UK; 3 UnivofStellenbosch,CapeTown,SouthAfrica; 4 ZAMBART,Lusaka,Zambia 11:00 115 Optimising South Africa’s HIV Response: Results of the HIV and TB Investment Case

Calvin Chiu 1 ; Gesine Meyer-Rath 2 ; Leigh F. Johnson 3 ;Tom Sumner 4 ;Teresa Guthrie 5 ;Yogan Pillay 6 ; Fareed Abdullah 7 ; Eva Kiwango 8 ; for the South African HIV andTB Investment Case TaskTeam and Steering Committee 1 Univof theWitwatersrand, Johannesburg,SouthAfrica; 2 Boston Univ,Boston,MA,USA; 3 UnivofCapeTown,CapeTown,South Africa; 4 LondonSchofHygiene&TropMed,London,UK; 5 Guthrie HlthFinancingConsult,CapeTown,SouthAfrica; 6 NatlDeptof Hlth,Pretoria,SouthAfrica; 7 SouthAfricanNatlAIDSCouncil, Pretoria,SouthAfrica; 8 UNAIDS-SouthAfrica,Pretoria,South Africa

37

CROI 2016